A MULTICENTRE TRIAL OF RECOMBINANT GROWTH HORMONE AND LOW DOSE OESTROGEN IN TURNER SYNDROME: NEAR FINAL HEIGHT ANALYSIS
সংরক্ষণ করুন:
JOHNSTON, D.I., ET AL., A MULTICENTRE TRIAL OF RECOMBINANT GROWTH HORMONE AND LOW DOSE OESTROGEN IN TURNER SYNDROME: NEAR FINAL HEIGHT ANALYSIS. ARCHIVES OF DISEASE IN CHILDHOOD, Vol. 84, no. 1 (2001), p. 76-81.
Ref.
100828
অবস্থান:
SIIS R.186 Archivo
Palabras clave:
Discapacidad, Hormonas, Síndrome de Turner, Tratamiento médico
Discapacidad, Hormonas, Síndrome de Turner, Tratamiento médico
অনুরূপ উপাদানগুলি: A MULTICENTRE TRIAL OF RECOMBINANT GROWTH HORMONE AND LOW DOSE OESTROGEN IN TURNER SYNDROME: NEAR FINAL HEIGHT ANALYSIS
- TURNER SYNDROME: EFFECT OF HORMONE THERAPIES ON HEIGHT VELOCITY AND ADULT HEIGHT
- FINAL HEIGHT IN GIRLS WITH TURNER'S SYNDROME TREATED WITH ONCE OR TWICE DAILY GROWTH HORMONE INJECTIONS
- METHIONYL HUMAN GROWTH HORMONE IN TURNER'S SYNDROME
- METABOLIC STUDIES OF GROWTH HORMONE AND OESTRADIOLTREATMENT IN TURNER'S SYNDROME
- GROWTH HORMONE SECRETION IN TURNER'S SYNDROME AND INFLUENCE OF OXANDROLONE AND ETHINYL OESTRADIOL
- RESULTS FROM THE FIRST 2 YEARS OF A CLINICAL TRIAL WITH RECOMBINANT DNA-DERIVED HUMAN GROWTH HORMONE (SOMATREM) IN TURNER'S SYNDROME